1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Dingwei YE and Zhang H: Current status and
development trend of renal cancer diagnosis and treatment in China.
Chine J Urol. 35:401–405. 2014.(In Chinese).
|
3
|
Xian WEI, Xinwen KE, Zhiquan HU, et al:
Clinical efficacy and safety of sunitinib in the treatment of
advanced renal cell carcinoma. J Mod Reprod Oncol. 9:133–136.
2017.(In Chinese).
|
4
|
Shuang WB, Zhang YH and Tong XN: Recent
researches on sarcomatoid renal cell carcinoma. E J Transl Med.
2:6–8. 2018.(In Chinese).
|
5
|
Zhang L, Wu B, Zha Z, Zhao H and Feng Y:
The prognostic value and clinicopathological features of
sarcomatoid differentiation in patients with renal cell carcinoma:
A systematic review and meta-analysis. Cancer Manag Res.
10:1687–1703. 2018. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang BY, Thompson RH, Lohse CM, Leibovich
BC, Boorjian SA, Cheville JC and Costello BA: A novel prognostic
model for patients with sarcomatoid renal cell carcinoma. BJU Int.
115:405–411. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
He H and Magi-Galluzzi C:
Epithelial-to-mesenchymal transition in renal neoplasms. Adv Anat
Pathol. 21:174–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kyriakopoulos CE, Chittoria N, Choueiri
TK, Kroeger N, Lee JL, Srinivas S, Knox JJ, Bjarnason GA, Ernst SD,
Wood LA, et al: Outcome of patients with metastatic sarcomatoid
renal cell carcinoma: Results from the international metastatic
renal cell carcinoma database consortium. Clin Genitourin Cancer.
13:e79–e85. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lebacle C, Pooli A, Bessede T, Irani J,
Pantuck AJ and Drakaki A: Epidemiology, biology and treatment of
sarcomatoid RCC: Current state of the art. World J Urol.
37:115–123. 2019. View Article : Google Scholar : PubMed/NCBI
|
10
|
Appleman LJ and Marachie JK: Systemic
therapy following metastasectomy for renal cell carcinoma: Using
insights from other clinical settings to address unanswered
questions. Urol Oncol. 36:17–22. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nanus DM, Garino A, Milowsky MI, Larkin M
and Dutcher JP: Active chemotherapy for sarcomatoid and rapidly
progressing renal cell carcinoma. Cancer. 101:1545–1551. 2004.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Rashid MH, Welsh CT, Bissada NK and
Chaudhary UB: Complete response to adriamycin and ifosfamide in a
patient with sarcomatoid renal cell carcinoma. Am J Clin Oncol.
28:107–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Keskin SK, Msaouel P, Hess KR, Yu KJ,
Matin SF, Sircar K, Tamboli P, Jonasch E, Wood CG, Karam JA and
Tannir NM: Outcomes of patients with renal cell carcinoma and
sarcomatoid dedifferentiation treated with nephrectomy and systemic
therapies: Comparison between the cytokine and targeted therapy
eras. J Urol. 198:530–537. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shuch B, Bratslavsky G, Shih J, Vourganti
S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW and
Belldegrun AS: Impact of pathological tumour characteristics in
patients with sarcomatoid renal cell carcinoma. BJU Int.
109:1600–1606. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kim T, Zargar-Shoshtari K, Dhillon J, Lin
HY, Yue B, Fishman M, Sverrisson EF, Spiess PE, Gupta S, Poch MA
and Sexton WJ: Using percentage of sarcomatoid differentiation as a
prognostic factor in renal cell carcinoma. Clin Genitourin Cancer.
13:225–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen JH, Liu XD and Yang LI: Sarcomatoid
renal cell carcinoma: One case report. J Kun Ming Med Univ.
29:483–484. 2007.
|
17
|
Pei XK, Jiang W, Yang SB, Yang QS and Long
W: A case of ipsilateral renal sarcomatoid renal cell carcinoma
with angiomyolipoma at the same time and literature review. J
Contemp Urol Reproduct Oncol. 304–305. 2014.
|
18
|
Yin MX, Zhang Y, Ye XQ, Lin B and Xiao C:
Sarcomatoid renal cell carcinoma: Two case reports. Chin J Clin Exp
Pathol. 26:767–768. 2010.(In Chinese).
|
19
|
Li L and Zhou GY: Sarcomatoid renal cell
carcinoma: Two case reports. Chin J Clin Exp Pathol. 20:3842004.(In
Chinese).
|
20
|
Hu YC, Huang XY, Li D, Leng J, Bo JJ and
Wang YX: Sarcomatoid renal cell carcinoma: One case report. Chin J
Urol. 23:2172002.(In Chinese).
|
21
|
Komeya M, Sano F, Kagota M, Murakami T,
Makiyama K, Miyoshi Y, Nakaigawa N, Ogawa T, Uemura H, Yao M, et
al: Case of sarcomatoid renal cell carcinoma developed in the
chalked kidney (putty kidney). Hinyokika Kiyo. 55:253–257. 2009.(In
Japanese). PubMed/NCBI
|
22
|
Ni XH, Yu GH, Ruan ZY, Lin J and Cai FB:
Sarcomatoid renal cell carcinoma: Three cases report. Chin J Urol.
21:506–507. 2000.(In Chinese).
|
23
|
Gao Y, Shuang WB, Tong XN, Li S and Zhang
YH: Bilateral sarcomatoid renal cell carcinoma: An uncommon case in
young femal patient. Transl Surg. 2:74–77. 2017. View Article : Google Scholar
|
24
|
Takada T, Kinouchi T, Kinoshita T, Hatano
K, Kobayashi M, Inoue H, Hara T and Yamaguchi S: Four cases of
sarcomatoid renal cell carcinoma. Hinyokika Kiy. 55:93–97. 2009.(In
Japanese).
|
25
|
Tsuchiyama K, Ito H, Ishida H, Itoh H and
Yokoyama O: Advanced sarcomatoid renal cell carcinoma effectively
treated with sunitinib: Report of a case. Hinyokika Kiy.
57:615–618. 2011.
|
26
|
Minagawa T, Nishizawa S, Kamigaito M,
Nakayama T and Okaneya T: Sarcomatoid renal cell carcinoma with von
Hippel-Lindau disease: A case report. Nihon Hinyokika Gakkai
Zasshi. 98:723–726. 2007.(In Japanese). PubMed/NCBI
|
27
|
Kwak C, Park YH, Jeong CW, Jeong H, Lee
SE, Moon KC and Ku JH: Sarcomatoid differentiation as a prognostic
factor for immunotherapy in metastatic renal cell carcinoma. J Surg
Oncol. 95:317–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Cangiano T, Liao J, Naitoh J, Dorey F,
Figlin R and Belldegrun A: Sarcomatoid renal cell carcinoma:
Biologic behavior, prognosis, and response to combined surgical
resection and immunotherapy. J Clin Oncol. 17:523–528. 1999.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Stadler WM, Huo D, George C, Yang X, Ryan
CW, Karrison T, Zimmerman TM and Vogelzang NJ: Prognostic factors
for survival with gemcitabine plus 5-fluorouracil based regimens
for metastatic renal cancer. J Urol. 170:1141–1145. 2003.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Motzer RJ and Russo P: Systemic therapy
for renal cell carcinoma. J Urol. 163:408–417. 2000. View Article : Google Scholar : PubMed/NCBI
|
31
|
Motzer RJ, Rini BI, Bukowski RM, Curti BD,
George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G,
et al: Sunitinib in patients with metastatic renal cell carcinoma.
JAMA. 295:2516–2624. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
Dodd PM, McCaffrey JA, Hilton S, Mazumdar
M, Herr H, Kelly WK, Icasiano E, Boyle MG and Bajorin DF: Phase I
evaluation of sequential doxorubicin gemcitabine then ifosfamide
paclitaxel cisplatin for patients with unresectable or metastatic
transitional-cell carcinoma of the urothelial tract. J Clin Oncol.
18:840–846. 2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Bono AV and Lovisolo JA: Renal cell
carcinoma-diagnosis and treatment: State of the art. Eur Urol. 31
(Suppl 1):S47–S55. 1997. View Article : Google Scholar
|
34
|
Zhang L, Shi HY and Hong BF: The
clinicopathological analysis of 16 cases of sarcomatoid renal cell
carcinoma. Med J Chin PLA. 356–358. 2006.
|
35
|
Grabowski M, Huzarski T, Lubinski J and
Sikorski A: Survival in patients with rare subtypes of renal cell
carcinoma. BJU Int. 89:599–600. 2002. View Article : Google Scholar : PubMed/NCBI
|
36
|
Leibovich BC, Han KR, Bui MH, Pantuck AJ,
Dorey FJ, Figlin RA and Belldegrun A: Scoring algorithm to predict
survival after nephrectomy and immunotherapy in patients with
metastatic renal cell carcinoma: A stratification tool for
prospective clinical trials. Cancer. 98:2566–2575. 2003. View Article : Google Scholar : PubMed/NCBI
|
37
|
Escudier B, Szczylik C, Eisen T, Stadler
WM, Schwartz B and Bukowski MSM: Randomized phase III trial of the
Raf kinase and VEGFR inhibitor sorafenib (BAY 43-9006) in patients
with advanced renal cell carcinoma (RCC). J Clin Oncol.
23:45102005. View Article : Google Scholar
|
38
|
Culine S, Bkradda M, Terrier-Lacombe MJ
and Droz JP: Treatment of sarcomatoid renal cell carcinoma: Is
there a role for chemotherapy? Eur Urol. 27:138–141. 1995.
View Article : Google Scholar : PubMed/NCBI
|